Related Experiment Video

Updated: Sep 21, 2025

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
15:53

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

15.1K

Cdh1 Deficiency Sensitizes TNBC Cells to PARP Inhibitors

Junjun Li1, Mengjiao Lan2, Jin Peng2

  • 1Department of Abdominal Oncology, West China Hospital, Sichuan University, Chengdu 610000, China.

Genes
|May 28, 2022
PubMed

Insights

High Cdh1 expression drives triple-negative breast cancer (TNBC) progression. Targeting anaphase promoting complex (APC)/Cdh1 enhances PARP inhibitor effectiveness, offering a new therapeutic strategy for TNBC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Triple-negative breast cancer (TNBC) lacks targeted therapy options.
  • Anaphase promoting complex (APC) coactivator Cdh1 expression is elevated in TNBC.
  • High Cdh1 levels correlate with poor TNBC prognosis.

Purpose of the Study:

  • Investigate the role of Cdh1 in TNBC progression.
  • Determine if Cdh1 is a viable therapeutic target for TNBC.
  • Evaluate the combination of targeting Cdh1 with PARP inhibitors.

Main Methods:

  • Quantitative analysis of Cdh1 expression in TNBC tissues.
  • Functional assays to assess the impact of Cdh1 interference on TNBC cells.
  • Evaluation of combination therapy effects with PARP inhibitors (PARPi).

Main Results:

  • Cdh1 expression is significantly higher in TNBC compared to healthy tissue.
  • Elevated Cdh1 is linked to poorer patient outcomes.
  • Inhibiting Cdh1 potentiates PARPi efficacy by inducing DNA damage, cell cycle arrest, and apoptosis.
  • Cdh1 influences BRCA1 foci formation and DNA repair under PARPi treatment.

Conclusions:

  • APC/Cdh1 is implicated in TNBC progression.
  • Targeting APC/Cdh1 represents a promising strategy to enhance PARPi therapy for TNBC.
  • This study identifies APC/Cdh1 as a potential molecular target for overcoming TNBC treatment resistance.
Keywords:
BRCA1Cdh1PARPolaparibtriple-negative breast cancer

More Related Videos

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer04:20

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer

Published on: February 9, 2024

1.1K
Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

4.2K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K